These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1213 related articles for article (PubMed ID: 27743524)

  • 1. The GABAergic septohippocampal connection is impaired in a mouse model of tauopathy.
    Soler H; Dorca-Arévalo J; González M; Rubio SE; Ávila J; Soriano E; Pascual M
    Neurobiol Aging; 2017 Jan; 49():40-51. PubMed ID: 27743524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential accumulation of Tau phosphorylated at residues Thr231, Ser262 and Thr205 in hippocampal interneurons and its modulation by Tau mutations (VLW) and amyloid-β peptide.
    Dávila-Bouziguet E; Targa-Fabra G; Ávila J; Soriano E; Pascual M
    Neurobiol Dis; 2019 May; 125():232-244. PubMed ID: 30553886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerated aging of the GABAergic septohippocampal pathway and decreased hippocampal rhythms in a mouse model of Alzheimer's disease.
    Rubio SE; Vega-Flores G; Martínez A; Bosch C; Pérez-Mediavilla A; del Río J; Gruart A; Delgado-García JM; Soriano E; Pascual M
    FASEB J; 2012 Nov; 26(11):4458-67. PubMed ID: 22835830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional protection in J20/VLW mice: a model of non-demented with Alzheimer's disease neuropathology.
    Dávila-Bouziguet E; Casòliba-Melich A; Targa-Fabra G; Galera-López L; Ozaita A; Maldonado R; Ávila J; Delgado-García JM; Gruart A; Soriano E; Pascual M
    Brain; 2022 Apr; 145(2):729-743. PubMed ID: 34424282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective degeneration of septal and hippocampal GABAergic neurons in a mouse model of amyloidosis and tauopathy.
    Loreth D; Ozmen L; Revel FG; Knoflach F; Wetzel P; Frotscher M; Metzger F; Kretz O
    Neurobiol Dis; 2012 Jul; 47(1):1-12. PubMed ID: 22426397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tau pathology induces loss of GABAergic interneurons leading to altered synaptic plasticity and behavioral impairments.
    Levenga J; Krishnamurthy P; Rajamohamedsait H; Wong H; Franke TF; Cain P; Sigurdsson EM; Hoeffer CA
    Acta Neuropathol Commun; 2013 Jul; 1():34. PubMed ID: 24252661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective Disruption of Inhibitory Synapses Leading to Neuronal Hyperexcitability at an Early Stage of Tau Pathogenesis in a Mouse Model.
    Shimojo M; Takuwa H; Takado Y; Tokunaga M; Tsukamoto S; Minatohara K; Ono M; Seki C; Maeda J; Urushihata T; Minamihisamatsu T; Aoki I; Kawamura K; Zhang MR; Suhara T; Sahara N; Higuchi M
    J Neurosci; 2020 Apr; 40(17):3491-3501. PubMed ID: 32265258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRNA Levels of ACh-Related Enzymes in the Hippocampus of THY-Tau22 Mouse: A Model of Human Tauopathy with No Signs of Motor Disturbance.
    García-Gómez BE; Fernández-Gómez FJ; Muñoz-Delgado E; Buée L; Blum D; Vidal CJ
    J Mol Neurosci; 2016 Apr; 58(4):411-5. PubMed ID: 26697857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reelin reverts biochemical, physiological and cognitive alterations in mouse models of Tauopathy.
    Rossi D; Gruart A; Contreras-Murillo G; Muhaisen A; Ávila J; Delgado-García JM; Pujadas L; Soriano E
    Prog Neurobiol; 2020 Mar; 186():101743. PubMed ID: 31870804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylated tau in neuritic plaques of APP(sw)/Tau (vlw) transgenic mice and Alzheimer disease.
    Pérez M; Morán MA; Ferrer I; Avila J; Gómez-Ramos P
    Acta Neuropathol; 2008 Oct; 116(4):409-18. PubMed ID: 18679696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved long-term potentiation and memory in young tau-P301L transgenic mice before onset of hyperphosphorylation and tauopathy.
    Boekhoorn K; Terwel D; Biemans B; Borghgraef P; Wiegert O; Ramakers GJ; de Vos K; Krugers H; Tomiyama T; Mori H; Joels M; van Leuven F; Lucassen PJ
    J Neurosci; 2006 Mar; 26(13):3514-23. PubMed ID: 16571759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rifampicin is a candidate preventive medicine against amyloid-β and tau oligomers.
    Umeda T; Ono K; Sakai A; Yamashita M; Mizuguchi M; Klein WL; Yamada M; Mori H; Tomiyama T
    Brain; 2016 May; 139(Pt 5):1568-86. PubMed ID: 27020329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease brain-derived extracellular vesicles spread tau pathology in interneurons.
    Ruan Z; Pathak D; Venkatesan Kalavai S; Yoshii-Kitahara A; Muraoka S; Bhatt N; Takamatsu-Yukawa K; Hu J; Wang Y; Hersh S; Ericsson M; Gorantla S; Gendelman HE; Kayed R; Ikezu S; Luebke JI; Ikezu T
    Brain; 2021 Feb; 144(1):288-309. PubMed ID: 33246331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperphosphorylated tau causes reduced hippocampal CA1 excitability by relocating the axon initial segment.
    Hatch RJ; Wei Y; Xia D; Götz J
    Acta Neuropathol; 2017 May; 133(5):717-730. PubMed ID: 28091722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trehalose ameliorates dopaminergic and tau pathology in parkin deleted/tau overexpressing mice through autophagy activation.
    Rodríguez-Navarro JA; Rodríguez L; Casarejos MJ; Solano RM; Gómez A; Perucho J; Cuervo AM; García de Yébenes J; Mena MA
    Neurobiol Dis; 2010 Sep; 39(3):423-38. PubMed ID: 20546895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hippocampal tauopathy in tau transgenic mice coincides with impaired hippocampus-dependent learning and memory, and attenuated late-phase long-term depression of synaptic transmission.
    Van der Jeugd A; Ahmed T; Burnouf S; Belarbi K; Hamdame M; Grosjean ME; Humez S; Balschun D; Blum D; Buée L; D'Hooge R
    Neurobiol Learn Mem; 2011 Mar; 95(3):296-304. PubMed ID: 21167950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tau accumulation in the retina promotes early neuronal dysfunction and precedes brain pathology in a mouse model of Alzheimer's disease.
    Chiasseu M; Alarcon-Martinez L; Belforte N; Quintero H; Dotigny F; Destroismaisons L; Vande Velde C; Panayi F; Louis C; Di Polo A
    Mol Neurodegener; 2017 Aug; 12(1):58. PubMed ID: 28774322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hippocampal phosphorylated tau induced cognitive decline, dendritic spine loss and mitochondrial abnormalities in a mouse model of Alzheimer's disease.
    Kandimalla R; Manczak M; Yin X; Wang R; Reddy PH
    Hum Mol Genet; 2018 Jan; 27(1):30-40. PubMed ID: 29040533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A2A adenosine receptor deletion is protective in a mouse model of Tauopathy.
    Laurent C; Burnouf S; Ferry B; Batalha VL; Coelho JE; Baqi Y; Malik E; Mariciniak E; Parrot S; Van der Jeugd A; Faivre E; Flaten V; Ledent C; D'Hooge R; Sergeant N; Hamdane M; Humez S; Müller CE; Lopes LV; Buée L; Blum D
    Mol Psychiatry; 2016 Jan; 21(1):97-107. PubMed ID: 25450226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 61.